Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Pan

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Antiviral Therapy|March 26, 2004
Strategies to decrease viral load rebound, and prevent loss of CD4 and onset of resistance during structured treatment interruptionsAndrea Foli, Renato Maserati, Gabriele Barasolo, et al.
International Journal of Antimicrobial Agents|May 27, 2018
The GISA call to action for the appropriate use of antimicrobials and the control of antimicrobial resistance in ItalyFrancesco Menichetti, Marco Falcone, Pierluigi Lopalco, et al.
Polish Journal of Radiology|April 8, 2021
COVID-19: high-resolution computed tomography findings in the first 64 patients admitted to the Hospital of Cremona, the epicentre of the pandemic in EuropeVittorio Sabatino, Pietro Sergio, Margherita Muri, et al.
Plos One|May 29, 2015
Risk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+ T-Cell Counts >200+/μl Despite Effective HAARTGiuseppe Lapadula, Liliane Chatenoud, Andrea Gori, et al.
The American Journal of Dermatopathology|January 6, 2021
Acute Generalized Exanthematous Pustulosis (AGEP) in 12 Patients Treated for SARS-CoV-2 Positive PneumoniaEnrico Pezzarossa, Marco Ungari, Gioachino Caresana, et al.
The New Microbiologica|November 12, 2014
Monotherapy with lopinavir/ritonavir versus standard of care in HIV-infected patients virologically suppressed while on treatment with protease inhibitor-based regimens: results from the MoLo studyNicola Gianotti, Andrea Poli, Massimo Galli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 16, 2021
Multisocieties position paper: Microbiological surveillance on flexible endoscopesBeatrice Casini, Angelo Pan, Alessandra Guarini, et al.
BMC Infectious Diseases|May 1, 2014
Predicting the occurrence of embolic events: an analysis of 1456 episodes of infective endocarditis from the Italian Study on Endocarditis (SEI)Marco Rizzi, Veronica Ravasio, Alessandra Carobbio, et al.
Internal and Emergency Medicine|August 26, 2020
Prevalence of asymptomatic deep vein thrombosis in patients hospitalized with SARS-CoV-2 pneumonia: a cross-sectional studyMatteo Giorgi-Pierfranceschi, Oriana Paoletti, Angelo Pan, et al.
BMC Infectious Diseases|March 17, 2017
Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohortMaria Concetta Postorino, Mattia Prosperi, Emanuele Focà, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Antiviral Therapy|March 26, 2004
Strategies to decrease viral load rebound, and prevent loss of CD4 and onset of resistance during structured treatment interruptionsAndrea Foli, Renato Maserati, Gabriele Barasolo, et al.
International Journal of Antimicrobial Agents|May 27, 2018
The GISA call to action for the appropriate use of antimicrobials and the control of antimicrobial resistance in ItalyFrancesco Menichetti, Marco Falcone, Pierluigi Lopalco, et al.
Polish Journal of Radiology|April 8, 2021
COVID-19: high-resolution computed tomography findings in the first 64 patients admitted to the Hospital of Cremona, the epicentre of the pandemic in EuropeVittorio Sabatino, Pietro Sergio, Margherita Muri, et al.
Plos One|May 29, 2015
Risk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+ T-Cell Counts >200+/μl Despite Effective HAARTGiuseppe Lapadula, Liliane Chatenoud, Andrea Gori, et al.
The American Journal of Dermatopathology|January 6, 2021
Acute Generalized Exanthematous Pustulosis (AGEP) in 12 Patients Treated for SARS-CoV-2 Positive PneumoniaEnrico Pezzarossa, Marco Ungari, Gioachino Caresana, et al.
The New Microbiologica|November 12, 2014
Monotherapy with lopinavir/ritonavir versus standard of care in HIV-infected patients virologically suppressed while on treatment with protease inhibitor-based regimens: results from the MoLo studyNicola Gianotti, Andrea Poli, Massimo Galli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 16, 2021
Multisocieties position paper: Microbiological surveillance on flexible endoscopesBeatrice Casini, Angelo Pan, Alessandra Guarini, et al.
BMC Infectious Diseases|May 1, 2014
Predicting the occurrence of embolic events: an analysis of 1456 episodes of infective endocarditis from the Italian Study on Endocarditis (SEI)Marco Rizzi, Veronica Ravasio, Alessandra Carobbio, et al.
Internal and Emergency Medicine|August 26, 2020
Prevalence of asymptomatic deep vein thrombosis in patients hospitalized with SARS-CoV-2 pneumonia: a cross-sectional studyMatteo Giorgi-Pierfranceschi, Oriana Paoletti, Angelo Pan, et al.
BMC Infectious Diseases|March 17, 2017
Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohortMaria Concetta Postorino, Mattia Prosperi, Emanuele Focà, et al.
Pageof 8